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TELEPSYCHOTHERAPY FOR TRICHOTILLOMANIA
Abstract
Despite its prevalence, quality treatment for trichotillomania is often difficult to find. The use of
telepsychology has been an effective method for disseminating treatment services for a variety of
mental health conditions. However, no research has examined the use of telepsychology to treat
trichotillomania. This randomized controlled trial used Acceptance and Commitment Therapy
Enhanced Behavior Therapy delivered by way of telepsychology to treat trichotillomania in
adults. The study compared an active treatment condition (n = 12) to a delayed treatment waitlist
control condition (n = 10). Results showed significant reductions in hair pulling severity from
pre- to post-treatment compared to the waitlist condition. The 22 participants all received
treatment and were combined to examine overall treatment effects from pre-treatment to a 12week follow-up. The effect of treatment on hair pulling severity remained significant at followup. Measures of psychological flexibility and perceived shame also saw significant
improvement. Quality of life, however, did not improve over the course of treatment. The
findings demonstrate that telepsychology is a viable option to disseminate treatment for
trichotillomania.
Keywords: telepsychology, telehealth, trichotillomania, acceptance and commitment
therapy, habit reversal training, randomized controlled trial
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Telepsychotherapy for Trichotillomania: A Randomized Controlled Trial of
ACT Enhanced Behavior Therapy
Trichotillomania is characterized by repetitive hair pulling that leads to noticeable hair
loss and causes significant distress and social or functional impairment (American Psychiatric
Association, 2013). The dysfunctional effects of trichotillomania may include significant social
interference, such as the inability to maintain close relationships with others; occupational
interference, such as avoiding job interviews or position advancement; academic functioning,
such as missing school or having difficulties studying due to pulling; and affective disturbances,
such as depression, anxiety, or stress (Grant et al., 2017; Wetterneck, Woods, Norberg, &
Begotka, 2006; Woods et al., 2006a). Additionally, those with trichotillomania generally have
lower overall quality of life compared to healthy controls (Odlaug, Kim, & Grant, 2010).
The best estimates of the prevalence of trichotillomania range from 0.6% to 3.4% among
adults, dependent on how restrictively one defines the disorder (Christenson, Pyle, & Mitchell,
1991; Duke, Keeley, Geffken, & Storch, 2010; Stanley, Borden, Bell, & Wagner, 1994). Despite
its prevalence, trichotillomania continues to be misunderstood by many mental health
professionals. For example, a survey of over 500 psychologists and physicians in the United
States found that professionals are relatively uninformed about trichotillomania and its treatment
(Marcks, Wetterneck, & Woods, 2006). Additionally, the majority of the professionals surveyed
did not have referral resources to direct those with trichotillomania to find quality help.
Thus, finding quality treatment for trichotillomania may be impossible depending on
location. The United States Department of Health and Human Services (2014) estimated that
there are approximately 4,000 Mental Health Professional Shortage Areas in the United States
that include 96.5 million people who do not have access to adequate mental health services. This
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lack of adequate mental health care presents a significant problem for those seeking treatment for
trichotillomania. The problem of providing care to those without access and the low number of
trained providers for trichotillomania can potentially be addressed through the use of technology
and telepsychotherapy.
The use of telepsychotherapy has been shown to be an effective method of treating a
wide variety of mental health conditions including, post-traumatic stress disorder (Gros, Yoder,
Tuerk, Lozano, & Acierno, 2011), schizophrenia (Rotondi et al., 2005), alcohol abuse (Frueh,
Henderson, & Myrick, 2005), insomnia (Lichstein et al., 2013), Tourette’s syndrome (Himle,
Olufs, Himle, Tucker, & Woods, 2010), agoraphobia (Alcañiz et al., 2003), and eating disorders
(Shingleton, Richards, & Thompson-Brenner, 2013). However, no research has been conducted
on the effectiveness of telehealth to treat trichotillomania.
Telepsychology refers to a type of telehealth that consists of the delivery of traditional
psychological services by way of technology-assisted means (Nelson, Bui, & Velasquez, 2011).
Telepsychology services might enable those with debilitating levels of anxiety, depression, or
shame, who might not be willing to attend a traditional therapy session, to receive treatment from
the safety and convenience of their own homes (Hedman et al., 2011; Maheu, Pulier,
McMenamin, & Posen, 2012). Additionally, the format allows therapists to provide services to
underserved areas and populations where access to quality care for less understood conditions,
such as trichotillomania, might be difficult to obtain.
While no study has tested the use of telepsychology for treating trichotillomania, research
is growing with regard to treatments delivered by way of traditional face-to-face methods. Habit
reversal training is the most extensively researched of these treatments. Over 30 controlled trials
have been performed that examined habit reversal training for multiple disorders with both
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children and adults (Twohig, Bluett, Morrison, & Woidneck, 2014). Despite this, habit reversal
training often fails to adequately target internal states associated with some pulling behavior.
This has lead researchers to modify habit reversal training in attempts to better target issues such
as anxiety, distress, and lack of motivation that are often present in trichotillomania. These
modifications have included addition of traditional cognitive behavior therapy techniques
(Lerner, Franklin, Meadows, Hembree, & Foa, 1999; Rangaswami, 1997), dialectical behavior
therapy (DBT; Keuthen et al., 2012), metacognitive therapy (Shareh, 2017), and acceptance and
commitment therapy (ACT; Twohig & Woods, 2004). While limited, the research on ACT as a
treatment for trichotillomania is promising.
ACT has been examined as a stand-alone treatment for trichotillomania and related
disorders. These include two small multiple-baseline across participants design studies (Crosby,
Dehlin, Mitchell, & Twohig, 2012; Twohig, Hayes, & Masuda, 2006) and a randomized
controlled trial treating adolescents and adults (Lee et al., in press). These studies provide
evidence for ACT as a stand-alone treatment for trichotillomania. More research has examined
ACT as an enhancement to habit reversal techniques. ACT-enhanced Behavior Therapy was
developed to target overt, automatic pulling through the use of behavioral techniques like habit
reversal training and covert, internal experiences that lead to focused pulling through the use of
ACT (Woods & Twohig, 2008a). An initial pilot study examined the use of an ACT-enhanced
behavior therapy protocol on six adults with trichotillomania utilizing a multiple-baseline across
participants design (Twohig & Woods, 2004). Four of the six participants reduced their hair
pulling behavior significantly and three were able to maintain their gains at three-month followup. Next, a follow-up RCT was performed with a larger sample size of 25, that also found
significant reductions in hair pulling (Woods, Wetterneck, & Flessner, 2006b). Another study
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examined ACT-enhanced behavior therapy with regard to the sequence in which the two types of
therapy (i.e., ACT and habit reversal training) are presented with five participants with
trichotillomania or skin picking (Flessner, Busch, Heideman, & Woods, 2008). The researchers
found that participants responded best when both ACT and habit reversal training were utilized,
but no differences were seen as a result of sequencing. Finally, a recent RCT including 85
participants found that an ACT-enhanced behavior therapy condition significantly outperformed
a psychoeducation and supportive therapy condition at post-treatment; however, this finding was
not maintained at a three-month follow-up (Woods et al., 2018). In summary, there is good
support for ACT-enhanced behavior therapy as a treatment for trichotillomania, making it a good
candidate for evaluation in a telepsychotherapy format.
At this time, no research has examined treatment of trichotillomania using
telepsychology. While treatment for trichotillomania has improved over time, access to providers
who are familiar with trichotillomania and its treatment has not. Telepsychology appears to be a
promising component to the solution of this problem. The current study is an attempt to examine
the feasibility of delivering ACT-enhanced behavior therapy as a treatment for trichotillomania
by way of telepsychology through the use of a randomized controlled trial. We predicted that
treatment would significantly improve hair pulling severity and quality of life compared to the
waitlist condition. Additionally, we predicted that psychological flexibility and shame, variables
that have previously been shown to be related to trichotillomania, would improve over the course
of treatment. Finally, we explored how telepsychology might affect working alliance and
treatment satisfaction.
Method
Participants
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Participants were recruited from multiple university campuses and mental health
providers as well as via advertising on the internet. To be included in the study, participants were
required to: (a) meet the DSM-5 criteria for trichotillomania; (b) be seeking treatment primarily
for trichotillomania-related concerns; (c) be at least 18 years old; (d) reside in Utah; and (e) be a
fluent English speaker. Participants were excluded from the study if they: (a) were currently
receiving psychotherapy; (b) had started or changed psychotropic medication in the past 30 days;
or (c) were planning to start or change psychotropic medication during the course of the current
study.
The majority of participants were women (86.4%), heterosexual (81.8%), and White
(95.5%). On average, participants were 32.5 (SD = 8.3) years old. Education varied among
participants with highest completion levels as follows: high school (13.6%), some college
(31.8%), bachelor’s degree (27.3%), and graduate degree (27.3%). Results of a diagnostic
interview indicated that seven (31.8%) participants met criteria for a comorbid psychological
disorder: persistent depressive disorder (18.2%), generalized anxiety disorder (13.6%), and major
depressive disorder (9.1%). Six met criteria for a single comorbid diagnosis and one met criteria
for four comorbid diagnoses. Additionally, six (27.3%) reported being on a stable dose of an
antidepressant and one (4.5%) reported being on a stable dose of a stimulant. On average,
participants reported that hair pulling had been a significant problem for 16.3 (SD = 9.7, range =
22–51) years. Moreover, 11 (50.0%) participants had previously sought individual therapy and
two (9.1%) had previously used self-help books as treatment for trichotillomania. Detailed
information regarding what type of prior treatment was not gathered. See Table 1 for
demographic data by condition.
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A power analysis was conducted using G*Power software (Faul, Erdfelder, Lang, &
Buchner, 2007) in order to determine the number of participants to include in the study. A past
trial of ACT-enhanced behavior therapy for trichotillomania resulted in a large effect size (d =
.81; Woods et al., 2006b). Therefore, a power analysis was performed using this same effect size,
with alpha set at .05 and power at .80 specifying a sample of 24. At the conclusion of the
recruitment period, 28 individuals were assessed for eligibility and 22 met requirements and
participated in the study. See Figure 1 for a participant flowchart.
Procedures
The current study was approved by a university internal review board. The effect of
treatment was assessed through a randomized controlled trial. Participants were randomized into
either a treatment or delayed treatment waitlist control group following the baseline assessment
during the intake process. An online random number generator was used to create a list of
participant identifiers that were randomly assigned to one of two equally sized groups. Following
the intake session, participants were given the next available identifier and assigned to the
corresponding group. The intake session consisted of gathering consent and information about
hair pulling and completing an assessment battery. Participants placed in the treatment group
completed this pretreatment assessment, tracked their baseline hair pulling for one week, and
then began the 12-week treatment. Participants in the delayed treatment waitlist group completed
the same pretreatment assessment, tracked their baseline hair pulling for one week, and then
began treatment after 12 weeks had elapsed and they had completed a post-waitlist assessment.
All participants were also given an assessment following their fifth treatment session, final
treatment session, and 12 weeks following treatment.
Telepsychology Procedures
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All treatment sessions, including intake, utilized telepsychology procedures. Thus,
participants received all treatment in their homes while therapists were located in a private room
in a university clinic. A HIPAA approved video conferencing software (VSee) was utilized. All
sessions were recorded and saved to a HIPAA compliant server. All assessments were completed
using online survey software (Qualtrics).
Treatment
Treatment consisted of a protocol (see Table 2 for an overview) that took place over 10
individual weekly one-hour sessions. Of the participants who completed all 10 sessions, the
average treatment length was 12.7 weeks; flexibility allowed the treatment provider to
accommodate for scheduling conflicts or other participant needs. The protocol closely followed
an empirically supported acceptance and commitment therapy-enhanced behavior therapy
treatment manual (Woods & Twohig, 2008b). The manual blends traditional habit reversal
training techniques with more contemporary behavior therapy elements from ACT that employ
techniques to change the function of the urges to pull as well as the associated cognitions. The
first and second author, advanced graduate students, conducted the treatment for 15 and 7 of the
participants, respectively. Both therapists were supervised by the fifth author, a licensed
psychologist who co-authored the treatment manual on which the study treatment was based.
Measures
The Miniature International Neuropsychiatric Interview (MINI; Sheehan et al.,
1998). The MINI is a short, structured diagnostic interview assessing for Axis I symptoms as
outlined by the Diagnostic and Statistical Manual of Mental Disorders–Fourth Edition (DSM-IV;
American Psychiatric Association, 2000). It has been validated in numerous studies and is
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considered to be a more time-efficient alternative to longer structured measures (Sheehan et al.,
1998).
Massachusetts General Hospital Hair Pulling Scale (MGH-HPS; Keuthen, O'Sullivan,
Ricciardi, & Shera, 1995a). The MGH-HPS is a seven-item self-report measure that assesses
urges to pull hair, actual pulling behavior, and the distress caused from pulling. Individual items
are rated from 0 to 4 and are then summed into a 0 to 28 point total score, with higher scores
indicating a higher degree of hair pulling severity. Score reductions of seven points or more are
considered to be indicative of clinically significant treatment response and disorder remission
(Houghton et al., 2015). The MGH-HPS displays good internal consistency (α = .89; Keuthen et
al., 1995a), test-retest reliability (r = .97), and convergent and divergent validity (O'Sullivan et
al., 1995). The MGH-HPS demonstrated acceptable internal consistency in the current sample (α
= .75).
Quality of Life Scale (QOLS; Burckhardt, Woods, Schultz, & Ziebarth, 1989). The
QOLS is a 16-item self-report scale that measures several aspects of functional status including,
relationships, employment, health, and recreation. Items are rated on a seven-point Likert-type
scale that asks how satisfied the respondent is in these areas (1 = terrible to 7 = delighted).
Scores are then summed into a 16 to 112 point total score, with higher scores indicating greater
quality of life. The average total score for healthy populations is approximately 90 (Burckhardt
& Anderson, 2003). Score increases of seven to eight points generally indicate clinically
significant improvement (Burckhardt & Anderson, 2003). The QOLS has demonstrated good
internal consistency (α = .82 to .92) and test-retest reliability (r = .78 to .84; Burckhardt &
Anderson, 2003), as well as good convergent and divergent validity (Burckhardt, Anderson,
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Archenholtz, & Hägg, 2003). The QOLS demonstrated good internal consistency in the current
sample (α = .86).
Acceptance and Action Questionnaire for Trichotillomania (AAQ-TTM; Houghton et
al., 2014). The AAQ-TTM is a nine-item self-report measure of psychological inflexibility,
specifically designed for trichotillomania populations. Items are rated on a seven-point Likerttype scale (1 = never true to 7 = always true) that are then summed into a 7 to 63 point total
score, with higher scores indicating greater levels of psychological inflexibility. The AAQ-TTM
has demonstrated good internal consistency (α = .84; Houghton et al., 2014). It also
demonstrated good convergent and divergent validity as well as incremental validity over the
Acceptance and Action Questionnaire-II (Bond et al., 2011) from which it is based. The AAQTTM demonstrated questionable internal consistency in the current sample (α = .64); it is worth
noting this improved to .85 at posttreatment.
Experience of Shame Scale (ESS; Andrews, Qian, & Valentine, 2002). The ESS is a 25item measure of shame. Past and current experiences, cognitions, and behaviors related to shame
are measured on a four-point Likert-type scale (1 = Not at all to 4 = Very much) that are then
summed into a 25 to 100 point total score. The original validation study that included 163
undergraduate university students found a mean total score of 55.58 (13.95). The ESS has
demonstrated excellent internal consistency (α = .92) and test retest reliability (r = .83) as well as
convergent and divergent validity (Andrews et al., 2002). The ESS demonstrated excellent
internal consistency in the current sample (α = .95).
Working Alliance Inventory – Short Revised (WAI-SR; Hatcher & Gillaspy, 2006).
The WAI-SR is a 12-item self-report measure of perceived therapeutic alliance. The measure
consists of three factors: (a) goal agreement, agreement between the therapist and client
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regarding the goals of treatment; (b) task agreement, agreement on how to achieve these goals;
(c) and bond, the relationship and alliance between the therapist and client. Items are rated on a
five-point Likert-type scale (1 = seldom to 5 = always) that are then averaged into a 1 to 5 point
total score, with higher scores indicating greater levels of therapeutic alliance. The WAI-SR has
demonstrated good test-retest reliability (r = .85–.93) and convergent and divergent validity
(Hatcher & Gillaspy, 2006). The WAI-SR demonstrated excellent internal consistency in the
current sample (α = .98).
Client Satisfaction Questionnaire–8 (CSQ-8; Attkisson & Zwick, 1982). The CSQ-8 is
an eight-item version of the original Client Satisfaction Questionnaire (Larsen, Attkisson,
Hargreaves, & Nguyen, 1979). It is a single factor self-report measure of client satisfaction of
treatment. Items are rated on a four-point Likert-type scale where 1 indicates a low degree of
satisfaction and 4 indicates high satisfaction. Scores are summed into an 8 to 32 point total score
with high scores indicating greater levels of treatment satisfaction. The CSQ-8 has demonstrated
good internal consistency (α = .84–.93) as well as convergent and divergent validity. The CSQ-8
demonstrated excellent internal consistency in the current sample (α = .98).
Data Analytic Procedures
An intent-to-treat approach was taken for all analyses such that all collected data were
used, including dropouts. Data were analyzed using R statistical software (R Development Core
Team, 2016) and the following packages: car (Fox & Weisberg, 2011), lme4 (Bates, Maechler,
Bolker, & Walker, 2015), psy (Falissard, 2012), psych (Revelle, 2017), tidyverse (Wickham,
2017), and jmv (Selker, Love, & Dropmann, 2017).
Results
Treatment Adherence
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All sessions were video and audio recorded using the built-in recording function in VSee.
Twenty percent of all sessions were viewed and scored for the quantity and quality of the
coverage of each treatment component using a standardized treatment integrity scoring system
used in previous ACT research (Crosby & Twohig, 2016; Twohig & Crosby, 2010). Two
sessions from each 10-session treatment were systematically chosen such that each session
number was reviewed approximately five times. A graduate assistant reviewer who did not
provide treatment scored each of the 48 selected sessions. This reviewer had received coding
training for a previous project and scored reliably (above .90) with the author in the previous
project.
For every coded session, HRT consistent (i.e., awareness training, competing response
training, and contingency management), ACT consistent (i.e., acceptance, defusion, self as
context, present moment awareness, values clarification, and committed action), and ACT
inconsistent (i.e., cognitive challenging, experiential avoidant change strategies, and thoughts
and feelings cause action) behaviors were rated on a five-point Likert-type scale (1 = the
variable was never explicitly covered to 5 = the variable occurred with high frequency and was
covered in a very in-depth manner). Additionally, therapist adherence to the treatment model and
therapist competency were rated on the same scale. Means for each process were calculated in
order to give an overview of how often each process was targeted over the course of treatment on
average. This method was necessary due to the flexible nature of the treatment manual that
allowed for processes to be covered for different periods and out of order as deemed necessary
by the therapist and supervisor. The average score for each HRT process over the 10 sessions are
as follows: awareness training (M = 2.10, SD = 1.07), competing response training (M = 1.90, SD
= 1.09), and contingency management (M = 1.76, SD = 1.30). The average score for each ACT
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process are as follows: acceptance (M = 2.98, SD = 1.25), defusion (M = 2.49, SD = 1.38),
contact with the present moment (M = 1.98, SD = 1.08), self as context (M = 1.27, SD = 0.74),
values (M = 1.95, SD = 1.22), and committed action (M = 2.78, SD = 0.76). Of note, each
process was rated “5” for at least one session, indicating that each process was covered in an indepth manner. Moreover, therapist adherence to the treatment model and therapist competency
were rated highly (M = 4.00, SD = 0.67) and (M = 4.20, SD = 0.51), respectively. Finally, all
ACT inconsistent processes were rated “1” for every session, indicating that they were not
present. In summary, treatment adherence and therapist competency were highly rated.
Moreover, it appears that each process was thoroughly covered during at least one session and
acceptance, defusion, and committed action were on average covered more often than other
processes. Of note, no significant differences were found between participants assigned to the
two therapists on pre-post changes on any outcome variables, suggesting both therapists were
equally effective.
Differences Between Conditions
Descriptive statistics, including demographic information and means for each of the
measures at the various treatment stages were calculated for both the experimental and control
groups. Comparisons were then made between the groups, using Welche’s t-tests and Pearson’s
chi-squared tests to ensure that groups were similar at the beginning of the study with regard to
demographic, dependent, and independent variables. Internal consistency of each of the
identified measures was computed to establish scale reliability. No significant differences
between treatment and waitlist conditions were found for any variables at intake (ps > .05), thus
indicating that the groups were similar upon entering the study. See Table 1 for complete
comparison data.
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Condition Comparison Summary
The primary outcomes of interest were the severity of trichotillomania symptoms (as
measured by the MGH-HPS) and quality of life (as measured by the QOLS). ANCOVAs were
used to assess the effect of the treatment condition on post-treatment trichotillomania symptom
severity and quality of life after controlling for pre-treatment levels compared to the waitlist
condition. Mid-treatment assessments were only gathered from the treatment group; therefore,
mid-treatment scores are only included in the combined group analysis. Post-treatment scores
were entered as a dependent variable, treatment condition was entered as an independent
variable, and pre-treatment scores were entered as a covariate. Effect sizes are reported using ω²,
as it produces less biased and more conservative effect sizes compared to η², especially in small
samples (Albers & Lakens, 2017). ω² can be interpreted using the same rough criteria as η² (i.e.,
small = 0.01, medium = 0.06, large = 0.14). Post hoc analyses were performed with a Bonferroni
adjustment.
Table 3 summarizes outcome variable means and standard deviations for the treatment
and waitlist groups at time 1 (pre-treatment and pre-waitlist) and time 2 (post-treatment and postwaitlist).
Effects on Hair Pulling Severity
After adjusting for pre-treatment MGH-HPS scores, there was a statistically significant
difference in post-treatment scores between conditions, F(1, 18) = 19.627, p < .001, ω² = .473.
MGH-HPS scores were statistically significantly greater in the waitlist condition (18.10 ± 4.52)
compared to the treatment condition (9.00 ± 5.00), a mean difference of 9.32 (p < .001). The
treatment group displayed a 42.2% decrease in MGH-HPS scores, while the waitlist group
displayed a 17.7% increase from time 1 to time 2. Seven of the 12 (58.3%) treatment completers
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saw MGH-HPS score reductions of seven points or greater, indicating clinically significant
improvement. These findings indicate that, on average, treatment had a significant, large effect
on hair pulling severity.
Effects on Quality of Life
After adjusting for pre-treatment QOLS scores, there was no statistically significant
difference in post-treatment scores between conditions, F(1, 18) = 1.910, p = .183, ω² = .032.
On average, the treatment groups displayed an 8.0% increase and the waitlist showed a 2.3%
decrease in QOLS scores, indicating a slight improvement in quality of life from pre- to posttreatment. This improvement was a nonsignificant change compared to the waitlist group.
Effects on Psychological Flexibility
After adjusting for pre-treatment AAQ-TTM scores, there was no statistically significant
difference in post-treatment scores between conditions, F(1, 18) = 3.790, p = .068, ω² = .064. On
average, the treatment groups displayed a 19.6% decrease in AAQ-TTM scores, indicating
improved trichotillomania-related psychological flexibility from pre- to post-treatment. This
improvement was a nonsignificant change compared to the waitlist group which displayed a
3.4% decrease in scores. Of note, changes in psychological flexibility from pre- to post-treatment
were significantly correlated with changes in trichotillomania severity (r = .55, p = .016). While
this relationship is of interest, further studies with larger samples are needed to examine potential
mediational effects of psychological flexibility on trichotillomania outcomes.
Effects on Shame
After adjusting for pre-treatment ESS scores, there was no statistically significant
difference in post-treatment scores between conditions, F(1, 18) = 3.360, p = .084, ω² = .032. On
average, the treatment groups displayed an 8.3% decrease in ESS scores, indicating a slight
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improvement in overall experienced shame from pre- to post-treatment. This improvement was a
nonsignificant change compared to the waitlist group which displayed a 5.6% increase in scores.
Combined Follow-up Analysis
Because both conditions eventually received treatment, data from all participants was
then combined. Mixed model repeated measures analyses were used to assess outcome across
pre-treatment, mid-point, post-treatment, and three-month follow-up. This method allows all
available data to be used to model change over time, even when there is missing data.
Participants were specified in the model as a random factor to control for interclass correlations
and time was specified as a fixed factor. Using chi-square tests on the log-likelihood values, this
model was compared to an intercept only model (excluding the time variable) and a model that
allowed for slopes to vary by participant. The model-fit was significantly better than the intercept
only model (ps < .01 and was not significantly improved by adding random slopes (ps > .10) for
all variables. Therefore, the original random intercept, fixed slopes model was retained and
utilized in all mixed model analyses. See Table 4 for a summary of outcome variable means and
standard deviations at each time point and Table 5 for results of the mixed models repeated
measures analyses.
Effects on Hair Pulling Severity
Significant improvements on MGH-HPS scores were observed from pre- to posttreatment, slope estimate = -6.13, SE = 1.30, t(58.48) = -4.72, p < .001. On average, scores
decreased 39.4% from pre- post-treatment with 12 (60.0%) participants demonstrating reductions
of seven points or greater, indicating clinically significant reductions in hair pulling severity.
This percentage decreased to 26.3% at follow-up with seven (36.8%) maintaining clinically
significant score reductions three months following treatment. On average, the score increases
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from post-treatment to follow-up were nonsignificant, slope estimate = -1.95, SE = 1.34, t(57.19)
= 1.45, p = .152.
Effects on Quality of Life
QOLS scores did not significantly change from pre- to post-treatment, slope estimate =
5.58, SE = 3.36, t(57.92) = 1.66, p = .103. On average, scores increased 6.9% from pre- to posttreatment with 11 (55.0%) participants demonstrating increases of seven points or greater,
indicating clinically significant increases in quality of life. This percentage decreased to 3.4% at
follow-up, with seven (36.8%) participants demonstrating clinically significant score increases
three months following treatment. On average, the score decreases from post-treatment to
follow-up were nonsignificant, slope estimate = 3.20, SE = 3.45, t(56.48) = 0.93, p = .358.
Effects on Psychological Flexibility
Significant improvements on AAQ-TTM scores were observed from pre- to posttreatment, slope estimate = -11.78, SE = 2.01, t(55.85) = -5.85, p < .001. On average, scores
decreased 28.1% from pre- to post-treatment and remained relatively stable through follow-up
with a 26.5% decrease from pre-treatment to follow-up. On average, the score increases from
post-treatment to follow-up were nonsignificant, slope estimate = 1.01, SE = 2.06, t(54.58) =
0.49, p = .627.
Effects on Shame
ESS scores decreased nonsignificantly from pre- to post-treatment, slope estimate = 2.54, SE = 2.54, t(56.37) = -1.00, p = .321. Scores decreased only 3.1% from pre- to posttreatment. However, at follow-up this change was 18.2% from pre-treatment. On average,
participants demonstrated a significant decrease in scores from post-treatment to follow-up, slope
estimate = -8.50, SE = 2.55, t(55.17) = -3.33, p = .002. In addition, the score began above the
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norm from the original validation study (+4.61) and decreased below it at follow-up (-6.32),
indicating meaningful changes in shame from pre-treatment to follow-up.
Telehealth Factors
At intake, participants were asked questions related to their reasons for seeking treatment
and whether the telehealth aspect of the treatment interested them. Forty percent of the
participants reported that they would not have been seeking treatment if it were not provided
over the internet. Moreover, 59.1% said that they were unable to find treatment for
trichotillomania where they lived. Thus, telehealth was the only feasible treatment option for
over half of the participants. Additionally, 50.0% reported that their busy schedule prohibited
them from seeking face-to-face therapy.
Working Alliance and Treatment Satisfaction
Participants were assessed for therapist-client working alliance following session five
(mid-treatment) and at post-treatment. For comparison, the mean WAI-SR scores at pretreatment (goal = 4.6, task = 3.9, bond = 4.6, total = 4.4) and at post-treatment (goal = 4.6, task =
4.4, bond = 4.5, total = 4.5) were all higher than the mean scores (goal = 4.0, task = 3.4, bond =
4.0, total = 3.8) gathered in the original development of the measure (Munder, Wilmers,
Leonhart, Linster, & Barth, 2010), indicating very good levels of perceived therapeutic alliance.
This is important as therapy was delivered via telehealth.
Participants were assessed for their satisfaction with treatment following session five
(mid-treatment), at post-treatment, and at follow-up. CSQ-8 scores were 3.65, 3.71, and 3.65,
respectively. No norms exist for the CSQ-8 to compare to the current sample, although an
original psychometric analysis of the measure reported mean scores of 3.02 from a sample of 45
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community mental health center patients (Attkisson & Zwick, 1982). Overall, scores indicated a
high level of treatment satisfaction.
Discussion
The current study examined whether ACT-enhanced behavior therapy could be
successfully delivered by way of telepsychology. The primary dependent measures were hair
pulling severity and quality of life. On average, participants in the treatment condition reported
significant, large reductions in hair pulling severity from pre- to post-treatment, compared to
those in the waitlist condition. However, reported quality of life did not improve in the same
manner, with only small, nonsignificant increases from pre- to post-treatment compared to the
waitlist condition.
Once the treatment and waitlist groups were combined and three-month follow-up data
were examined, the story of these outcomes shifts. As is typical for trichotillomania, rates of
symptom severity slightly, but not statistically significantly, increased on average following
treatment. Hair pulling severity rates at follow-up were still significantly lower than at the
beginning of treatment, but they were not as low as they were at post-treatment. Overall, these
rates of improvement are comparable to other ACT-enhanced behavior therapy trials. For
example, one trial found 44.8% and 24.0% decreases in MGH-HPS scores post-treatment and
follow-up, respectively, compared to 39.4% and 26.3% in the current trial (Woods et al., 2006b).
Quality of life did not significantly change on average over the course of treatment. Many
participants did see clinically significant rates of improvement in quality of life, however nearly
half (45.0%) did not see this level of improvement at post-treatment and nearly two thirds
(63.2%) did not at follow-up. Multiple factors may contribute to this unexpected outcome. There
is the possibility that treatment for trichotillomania does not impact quality of life. Yet,
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improvements in a behavior that is so often distressing and debilitating leads one to suspect that
quality of life would improve as this behavior also improves. Perhaps the broad measure of
quality of life used did not adequately capture trichotillomania-specific meaningful
improvements in participant’s lives as their hair pulling behavior decreased and their ability to
cope with their urges increased. It is also possible that participants did not adequately learn to
engage in behaviors related to quality of life over the course of treatment, such that they may
have reduced hair pulling behavior, but not replaced this with meaningful behavior. If this is the
case, future treatment research might examine ways to better increase values-consistent behavior
while still improving hair pulling severity. Finally, participants may simply require more time to
increase behaviors that improve their quality of life broadly. Research that examines these
constructs beyond a three-month follow-up period is needed.
On average, participants in the treatment condition did not report improved levels of
trichotillomania-related psychological flexibility or shame from pre- to post-treatment compared
to the waitlist condition. However, both constructs saw improvement in the desired direction on
average. Moreover, once the conditions were combined, psychological flexibility and shame saw
statistically significant improvements from pre-treatment to follow-up.
The pattern of improvement for shame is notable in that it remained relatively stable from
pre- to post-treatment but saw a statistically significant reduction following treatment. The ESS
demonstrates high levels of test-retest reliability over an 11-week period (.83), indicating that it
is measuring a trait-like disposition rather than a transient affective state. Therefore, it might take
some time before changes are demonstrated on this scale. Moreover, increased levels of
psychological flexibility could potentially play a role. Andrews et al. (2002) hypothesized that
shame may be part of a reciprocal interaction between dysfunctional, self-critical cognitions and
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self-evaluations that may amplify feelings of shame. As psychological flexibility increases, selfcritical thoughts may not be as meaningful and result in fewer feelings of shame. Moreover, the
experiences of shame might have less of an impact as one becomes more skilled at making space
for these experiences and not over-identifying with them. In other words, successful practice of
psychological flexibility means that shame can be present without having power over behavior.
The major purpose of the current study was to examine the feasibility of delivering
treatment for trichotillomania through telepsychotherapy. Overall, it appears that ACT-enhanced
behavior therapy can be successfully delivered using telepsychology methods. Findings from the
current study are similar to ACT-enhanced behavior therapy trials delivered by way of more
traditional face-to-face methods, providing further evidence for this treatment package. The
findings included significant reductions in hair pulling severity over the course of treatment with
similar levels of maintenance at follow-up to other trials.
In addition, participant ratings of treatment satisfaction and working alliance were high.
Intuitively, one might suspect that telepsychology would involve a tradeoff between the
technology and the therapist-participant relationship that might not favor these types of ratings.
However, it appears that treatment satisfaction and working alliance were at least as high as
similar face-to-face trials.
In part, the high treatment satisfaction ratings might be related to the unique qualities of
telepsychology. The convenience of participating in therapy from home cannot be overstated.
Multiple participants in the study reported being very time-constrained and appreciated the
flexibility of telepsychology. Indeed, half of participants reported that their busy schedule kept
them from attending face-to-face therapy. Another factor likely contributing to treatment
satisfaction is telepsychology’s ability to treat those who would otherwise be unable to find
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quality treatment. Half of participants reported having previously sought treatment for
trichotillomania and nearly 60% reported that treatment for trichotillomania was not available
near where they lived. Overall, it appears that the use of telepsychology in the current study led
to individuals receiving treatment who otherwise would not have due to inconvenience, lack of
availability, or lack of resources. Clearly, it addresses a crucial mental health disparity, and more
effective means of dissemination need to be explored.
Shame is another factor that may have kept people from previously seeking treatment and
that might have been mitigated by telepsychotherapy. Individuals with trichotillomania typically
have elevated levels of shame related to their urges and pulling behaviors (Stemberger, Thomas,
Mansueto, & Carter, 2000; Weingarden & Renshaw, 2015) and it appears that shame may be a
barrier to treatment for some (Singh, Wetterneck, Williams, & Knott, 2016). On average,
participants reported that trichotillomania had been a problem for over 16 years, yet half had not
sought treatment. The convenience and discretion that telepsychology offers individuals who
would perhaps otherwise be unwilling to seek therapy could be an important benefit of the
method. Future research should examine the role of experiences such as shame, guilt, and
embarrassment in seeking treatment and whether telepsychology improves rates of treatment
seeking among these individuals.
Among these benefits, telepsychotherapy also introduces some difficulties to
trichotillomania treatment. Real or perceived technical barriers may be intimidating to some as
they begin treatment. Additionally, technical difficulties such as dropped connections and lag
between the therapist and participant, can hinder treatment. Occasionally, the video conferencing
software did not function properly or the internet connection would be very poor requiring the
remainder of the session to be completed using the telephone. In total, 11 of the 197 (5.6%)

24
TELEPSYCHOTHERAPY FOR TRICHOTILLOMANIA
sessions required some use of the telephone. Lag or dropped connections were a more common
problem but did not severely negatively impact treatment.
There are limitations that should be accounted for when interpreting the findings of the
current study. The participant sample was diverse in some respects, but not others. The ratio of
male to female participants was typical of trichotillomania research, with women overrepresented. The sample was somewhat diverse with regard to sexual orientation, education,
marital status, income, and comorbid diagnoses, however, the vast majority (95.5%) of
participants were White. Future treatment studies should attempt to target more ethnically and
racially diverse populations. Very little trichotillomania research has examined non-White
populations and this study, unfortunately, is no different. Additionally, while well powered to
answer the main research question, the study was underpowered to sufficiently answer research
questions related to processes such as psychological flexibility and shame. Larger treatment trials
are needed to better examine processes of change in trichotillomania treatment. Moreover, all
collected data were self-report and were not assessed by an independent evaluator. This might
have led to imprecise evaluations of trichotillomania severity and overall treatment progress.
Future research would benefit from including an independent evaluator who is blind to condition.
One aspect of feasibility we failed to systematically assess for is the frequency of technical
barriers/issues that clients encountered while participating in telepsychotherapy sessions. Future
research should further examine relevant barriers and facilitators for clients receiving treatment
in this format. Finally, in general, treatment for trichotillomania is still lacking. While this study
demonstrated promising results for many participants, others simply did not respond to treatment
as well as we would like. Telepsychology and ACT-enhanced behavior therapy appear promising
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as a treatment modality, yet further research is needed to better understand those who do not
improve and to better tailor treatment to their needs.
These initial findings provide a foundation for future telepsychotherapy trichotillomania
treatment. Trichotillomania remains a challenging disorder to treat. Quality treatment is difficult
to find, shame and guilt often act as barriers to seeking treatment, and when treated, gains in
symptom improvement are difficult to maintain. Telepsychotherapy has the potential to
ameliorate each of these concerns. Modern technology provides the opportunity to rethink
traditional treatment conventions, offering more individualized services to more people. Future
research should explore this potential and expand on the foundation provided by this and other
telepsychology-related research.
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Table 1
Descriptive Statistics with Welche’s t-Test or Pearson’s Chi Squared Comparisons Between Groups
Treatment (n = 12)
Variable

n

%

Age

M
34.2

Waitlist (n = 10)
SD

n

%

9.4

M
30.4

SD
6.8

Sex
Male

1

8.3

2

20.0

Female

11

91.7

8

80.0

Race/ethnicity
White

12

100

9

90.0

Asian

-

-

1

10.0

Hispanic or Latinx

1

8.3

-

-

Education
High school

3

25.0

-

-

Some college

3

25.0

4

40.0

Bachelor’s degree

3

25.0

3

30.0

Graduate degree

3

25.0

3

30.0

t / X2

p

1.09

.29

.03

.87

.01

.93

2.99

.39

MGH-HPS

15.6

5.2

14.9

3.0

.38

.71

QOLS

80.0

13.3

81.6

12.2

.29

.77

AAQ-TTM

40.2

8.2

41.3

8.2

.32

.75

ESS

59.4

19.0

61.1

14.1

.24

.81

Note. AAQ-TTM = Acceptance and Action Questionnaire for Trichotillomania; ESS = Experience of
Shame Scale; MGH-HPS = Massachusetts General Hospital Hair Pulling Scale; QOLS = Quality of Life
Scale.
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Table 2
ACT/HRT for Trichotillomania: Treatment Manual Outline
Session

Treatment Components

Exercises/Content

Informed Consent

 Discuss added risks of telepsychology (e.g.,
privacy/confidentiality issues)

Psychoeducation and
Treatment Overview

 Basics of trichotillomania, behavioral model, environmental
triggers, emotional and cognitive factors related to pulling.
 Brief overview of what is to be expected throughout
treatment

Stimulus Control
Assessment

 Stimulus Control Assessment Form
 Introduce self-monitoring. Assign homework to monitor hair
pulling during the coming week

Habit Reversal Training

 Awareness training
 Competing response training

Stimulus Control

 Stimulus Control Assignment Sheet
 Identify stimulus control techniques to be used in contexts
where pulling is more likely to occur

3

Valuing

 Complete How Has Fighting Your Urges Affected You and
Writing Your Epitaph forms
 Discuss how attempts to control pulling have gotten in the
way of valued living

4

Creative Hopelessness and
the Control Agenda







5

Acceptance

 Examples of our inability to control bodily sensations,
emotions, thoughts, and urges to pull
 Discuss Paper in Shoe exercise
 Willingness as an alternative to the control agenda

Behavioral Commitments

 Develop behavioral commitment exercises to practice skills
outside of session
 Opportunities to follow values instead of controlling urges
 Success is determined by whether task is completed, not by
the levels of urges or distress
 Behavioral Commitment Worksheet

Defusion

 Defusion exercises that undermine the literality of language
and the negative effects due to this
 Exercises are at the discretion of the therapist

Being Present

Tree-on-the-Road Metaphor

Acting without Reasons

Playing with Urges in a Different Way

Evaluation versus Description

The Pull of Your Mind

1

2

6–7

What is currently being done to control urges?
Do these strategies work in the short/long-term?
Costs associated with the current strategies
Two-Games/tug-o-war/digging hole metaphor
Homework: Assign Paper in Shoe exercise
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Behavioral Commitments

8

Acceptance and Defusion as
Skills

Behavioral Commitments

9

Practicing ACT Skills

Relapse Prevention

10




Take Your Urges with You
Talking for the Client

 Agree to engage in new behavior commitment exercise in
addition to previous ones
 In-session exposure exercises
 Done in attempt to “make friends” or “get to know” the
urges, not necessarily reduce them
 During these exercises review acceptance, defusion, and
values in the moment, as needed
 Homework: Assign Making Friends with Your Urges
worksheet
 Agree to engage in new behavior commitment exercise in
addition to previous ones
 Continue in-session exposure exercises
 Allow client to practice ACT skills
 Have client review therapy up to this point
 Review important topics that have been discussed in past
sessions

Behavioral Commitments

 Agree to engage in new behavior commitment exercise in
addition to previous ones

Review

 Review what has been learned throughout therapy
 Review areas of importance for the client and clarify areas
where the client might be confused

Relapse Prevention
Celebrate Accomplishments

 Discus lapse versus relapse
 Vigilance in using habit reversal training
 Mindful to not return to old agenda
 Congratulate client on their progress
 Answer any questions about future issues
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Table 3
Outcome Means and Standard Deviations at Times 1 and 2 By Condition with F and Effect Size Statistics for
ANCOVA Comparisons Between Conditions at Time 2 Controlling for Differences at Time 1
Time 1
Treatment
(n = 12)
Variable

Time 2
Waitlist
(n = 10)

Treatment
(n = 11)

Waitlist
(n = 9)

M

SD

M

SD

M

SD

M

SD

F

ω²

p

MGH-HPS

15.58

5.21

14.90

3.00

9.00

4.52

18.10

5.00

19.63

.473

<.001

QOLS

80.00

13.25

81.60

12.21

86.91

15.10

79.70

12.65

1.91

.032

.183

AAQ-TTM

40.17

8.16

41.30

8.21

32.30

10.86

39.90

10.90

3.79

.064

.068

ESS

59.36

18.98

61.10

14.09

54.45

19.69

64.70

17.52

3.36

.032

.084

Note. AAQ-TTM = Acceptance and Action Questionnaire for Trichotillomania; ESS = Experience of Shame
Scale; MGH-HPS = Massachusetts General Hospital Hair Pulling Scale; QOLS = Quality of Life Scale.
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Table 4
Combined Outcome Means and Standard Deviations at Pre-, Mid-, and Post-Treatment and 3 Month
Follow-Up
Pre-treatment
(n = 22)
Variable

Mid-treatment
(n = 20)

Post-treatment
(n = 20)

Follow-up
(n = 19)

M

SD

M

SD

M

SD

M

SD

MGH-HPS

15.27

4.27

10.20

4.16

9.25

4.24

11.26

5.97

QOLS

80.73

12.51

85.50

12.94

86.70

16.47

83.71

19.06

AAQ-TTM

40.68

8.00

35.37

10.96

29.26

11.17

29.89

8.77

ESS

60.19

16.44

61.10

13.85

58.30

17.73

49.26

11.96

Note. AAQ-TTM = Acceptance and Action Questionnaire for Trichotillomania; ESS = Experience of
Shame Scale; MGH-HPS = Massachusetts General Hospital Hair Pulling Scale; QOLS = Quality of
Life Scale.

40
TELEPSYCHOTHERAPY FOR TRICHOTILLOMANIA
Table 5
Mixed Models Repeated Measures Results for Changes Within Treatment
Slope
Standard
df
t-value
p
Estimate
Error
MGH-HPS
Pre to Mid
-5.18
1.30
58.48
-3.99
< .001
Pre to Post
-6.13
1.30
58.48
-4.72
< .001
Pre to Follow-up
-4.18
1.32
58.92
-3.17
.002
Post to Follow-up
1.95
1.34
57.19
1.45
.152
QOLS
Pre to Mid
4.37
3.31
57.90
1.32
.192
Pre to Post
5.57
3.31
57.90
1.68
.098
Pre to Follow-up
2.48
3.37
58.06
0.74
.465
Post to Follow-up
3.09
3.40
56.46
0.91
.366
AAQ-TTM
Pre to Mid
-5.33
2.01
55.85
-2.65
.010
Pre to Post
-11.78
2.01
55.85
-5.85
< .001
Pre to Follow-up
-10.77
2.01
55.85
-5.35
< .001
Post to Follow-up
1.01
2.06
54.48
0.49
.627
ESS
Pre to Mid
0.26
2.54
56.37
0.10
.919
Pre to Post
-2.54
2.54
56.37
-1.00
.321
Pre to Follow-up
-11.04
2.58
56.44
-4.27
< .001
Post to Follow-up
-8.50
2.55
55.17
-3.33
.002
Note. AAQ-TTM = Acceptance and Action Questionnaire for Trichotillomania; ESS =
Experience of Shame Scale; MGH-HPS = Massachusetts General Hospital Hair Pulling
Scale; QOLS = Quality of Life Scale.
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One participant dropped out of the intervention following session 5 with no explanation. This participant
did not respond to contact attempts and did not complete the mid- and post-treatment and follow-up
assessments. b One participant did not respond to contact attempts following completion of the postwaitlist assessment. c Two participants dropped out of the intervention following sessions 7 and 8. Both
stated a lack of time to continue participation in the intervention. The first due to an injury in the family
that needed to be cared for. The second due to starting a new job. Both completed the post-treatment
assessment. d One participant did not respond to contact attempts to complete the follow-up assessment.
a

Figure 1. Participant Flowchart

